Join NAMI-NYC and Teva Pharmaceuticals virtually on Tuesday, December 6, from 6-7:30 PM, for an informative presentation on tardive dyskinesia (TD). Featuring guest speaker Stacy Finkbeiner, the U.S. Medical Director at Teva and a PhD level scientist.
We will discuss:
Tardive dyskinesia (pronunciation) is a movement disorder associated with taking antipsychotic medications. These drugs are used to treat many mental health conditions including schizophrenia. The literal meaning of the term “tardive dyskinesia” (TD) is delayed movement disorder. “Tardive” refers to the lagging or late onset, while “dyskinesia” refers to the abnormal or involuntary movements.
TD causes stiff, jerky movements of your face and body that you can’t control. You might blink your eyes, stick out your tongue, or wave your arms without meaning to do so.
Not everyone who takes an antipsychotic drug will get it. But if TD happens, it’s sometimes permanent.
Disclaimer: We cannot provide individual guidance on treatment options during this event. Please consult your provider.